MI
RNTX

Motiv8 Investments’s Rein Therapeutics RNTX Stock Holding History

Motiv8 Investments’s Portfolio RNTX Stock Details RNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$0 Buy
+25
New +$34 ﹤0.01% 1000

Other funds holding RNTX

VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Motiv8 Investments's RNTX Position: Q4 2025 in Review

Motiv8 Investments opened a new position in Rein Therapeutics (RNTX) in Q4 2025: 25 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1000 among its holdings.

48 funds tracked by Wall St. Rank hold RNTX as of Q4 2025.

  • Motiv8 Investments held 25 shares of Rein Therapeutics worth $0 as of Q4 2025.
  • Rein Therapeutics was a new Motiv8 Investments position in Q4 2025.
  • Rein Therapeutics made up ﹤0.01% of Motiv8 Investments's portfolio in Q4 2025, its #1000 holding.
  • 48 funds tracked by Wall St. Rank held Rein Therapeutics as of Q4 2025.

Based on Motiv8 Investments's 13F filing for Q4 2025, filed 13 Feb 2026.